A-1210477
CAS1668553-26-1
⚠ This product is for research use only, not for human or veterinary use.
We typically respond within 1 business day.
| CAS Number | 1803274-65-8 |
| IUPAC Name | 3-[2-[4-(trifluoromethoxy)anilino]-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid |
| Synonyms | Pan-Mutant-IDH1 Inhibitor Bay-1436032; RNMAUIMMNAHKQR-QFBILLFUSA-N; 3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid |
| Molecular Weight | 489.50 g/mol |
| Molecular Formula | C26H30F3N3O3 |
| PubChem CID | 118310260 |
| SMILES | CC1CC(CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F |
| Purity | >98% |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
BAY1436032 (CAS 1803274-65-8) is a pan-mutant isocitrate dehydrogenase 1 (IDH1) inhibitor with molecular formula C₂₆H₃₀F₃N₃O₃ and MW 489.50 g/mol. It is also known as Bay-1436032.
BAY1436032 is reported to selectively inhibit multiple oncogenic mutant forms of IDH1, including R132H, R132C, R132G, R132L, and R132S, without significant activity against the wild-type enzyme. It acts by binding the mutant IDH1 homodimer interface, suppressing the neomorphic production of the oncometabolite 2-hydroxyglutarate (2-HG) and thereby relieving downstream epigenetic dysregulation associated with IDH1-mutant malignancies.
Each batch is analyzed by HPLC and ¹H NMR, with a Certificate of Analysis provided on shipment. Available from milligram to kilogram scale, with flexible packaging to meet R&D and scale-up requirements.
All analytical documentation is provided free of charge with every order. Raw spectral data files (NMR, HPLC, LC-MS) are also available on request — just mention it in your enquiry.